查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1696296

全球微生物培养市场 - 2025 至 2033 年

Global Microbiology Culture Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球微生物培养市场规模达到 203.8 亿美元，预计到 2033 年将达到 402 亿美元，2025-2033 年预测期内的复合年增长率为 7.2%。

微生物培养是一种培养微生物以确定其身份、样本中的丰度或两者的方法。它是微生物学的主要诊断方法之一。培养微生物需要适当的物理环境，包括受控的 pH 值、大气气体、温度和压力。微生物培养基製备包括混合营养物质、缓衝剂、渗透平衡调节剂和选择性抑制剂或指示剂，以产生支持微生物生长和分化的琼脂或肉汤。该过程是微生物测试中监测腐败和致病微生物的常规任务。

最常见的方法是使用含有琼脂基生长培养基的培养皿，通常在培养箱中。另一种方法是液体培养，细菌悬浮在液体营养培养基中生长，通常会摇晃以保持均匀。

市场动态：

驱动因素与约束因素

传染病发生率上升

随着细菌、病毒和真菌感染（如结核病、登革热、肺炎、血流感染和医院内感染）的发病率不断增加，对微生物培养物的需求也日益增加，以检测和研究这些病原体。例如，根据世界卫生组织 2023 年的数据，全球约有 1,080 万人患有结核病 (TB)，其中包括 600 万名男性、360 万名女性和 130 万名儿童。结核病存在于所有国家和年龄人口中，并且可能再次成为全球单一传染源导致死亡的主要原因。

随着结核病的广泛流行和抗药性结核病菌株的威胁日益增加，对微生物培养技术的需求预计将增长，因为它们对于准确诊断、药物敏感性测试和治疗监测在应对这一持续的公共卫生挑战中仍然至关重要。对早期发现和控制疫情的需求日益增长，进一步加强了微生物培养市场。

严格的文化媒体生产规范架构

培养基生产的严格监管框架可能会对微生物培养市场造成重大限制，因为製造商必须遵守 FDA、EMA 和 ISO 等监管机构制定的严格品质、安全和性能标准。

这些法规要求进行大量的验证、无菌测试和品质控製程序，从而增加了新培养基产品的生产成本和上市时间。这些成本可能会对正在创新先进微生物系统或具有不同成分的微生物培养物的众多市场参与者造成障碍。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 按文化类型分类的片段
  • 一致性的片段
  • 按应用程式截取的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 传染病发生率上升
      • 增加微生物学和生命科学领域的研发投入
    • 限制
      • 严格的文化媒体生产规范架构
      • 污染和结果不一致的风险
    • 机会
      • 难培养微生物的创新培养基潜力
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：微生物培养市场（依产品类型）

  • 文化设备
    • 生物反应器
      • 生物反应器设备
      • 测量仪器
      • PH 感测器
      • 溶氧感知器
      • 温度感测器
      • 其他的
      • 分析设备
      • 细胞计数器
      • 光谱仪
      • 其他的
      • 灭菌设备
      • 孵化器
      • 其他的
  • 文化补编
  • 测量仪器
    • PH 感测器
    • 温度感测器
    • 溶氧感知器
    • 其他的
  • 文化仪器
    • 培养皿
    • 线圈与针
    • 微量移液器
    • 离心机
    • 其他的
  • 分析设备
    • 细胞计数器
    • 光谱仪
    • 其他的

第 6 章：微生物培养市场（依培养类型）

  • 真核培养
  • 细菌培养

第 7 章：微生物培养市场（按一致性）

  • 液体培养基
  • 固体培养基
  • 半固体培养基

第 8 章：微生物培养市场（按应用）

  • 药品
  • 食品饮料业
  • 其他的
  • 水质检测
  • 化妆品

第 9 章：微生物培养市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • Danaher (Cytiva)
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • BD
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Eiken Chemical co. Lti.
  • HiMedia Laboratories Pvt. Ltd
  • Kerry Group Plc
  • BioMerieux SA
  • Mettler Toledo
  • Yokogawa Electric Corporation
  • Conda Laboratories SA
  • SATAKE MultiMix Corporation
  • BE MARUBISHI CO., LTD.
  • ABLE Corporation & Biott Corporation

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: PH4443

The global microbiology culture market reached US$ 20.38 billion in 2024 and is expected to reach US$ 40.20 billion by 2033, growing at a CAGR of 7.2% during the forecast period 2025-2033.

A microbiology culture, or microbial culture, is a method of growing a microbial organism to determine its identity, its abundance in a sample, or both. It is one of the primary diagnostic methods in microbiology. Growing a microbial culture requires an appropriate physical environment with controlled pH, atmospheric gases, temperature, and pressure. Microbial culture media preparation involves mixing nutrients, buffering agents, osmotic balance regulators, and selective inhibitors or indicators to create agar or broth that supports microbial growth and differentiation. This process is a routine task in microbiological testing for monitoring spoilage and pathogenic microbes.

The most common method is using Petri dishes with agar-based growth medium, typically in an incubator. Another method is liquid culture, where bacteria are grown suspended in a liquid nutrient medium, often shaken to maintain uniformity.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Infectious Diseases

With the increasing incidence of bacterial, viral, and fungal infections, such as tuberculosis, dengue, pneumonia, bloodstream infections, and hospital-acquired infections, there is a growing need for microbial cultures to detect and study these pathogens. For instance, according to the World Health Organization in 2023, an estimated 10.8 million people worldwide fell ill with tuberculosis (TB), including 6.0 million men, 3.6 million women, and 1.3 million children. TB is present across all countries and age groups, and it has likely returned as the leading cause of death from a single infectious agent globally.

With its widespread prevalence and the increasing threat of drug-resistant TB strains, the demand for microbiological culture techniques is expected to grow, as they remain essential for accurate diagnosis, drug susceptibility testing, and treatment monitoring in combating this persistent public health challenge. The growing need for early detection and control of the outbreaks further strengthens the microbiology culture market.

Stringent Regulatory Framework for Culture Media Production

Stringent regulatory framework for culture media production could be a significant restraint for the microbiology culture market, as manufacturers must comply with strict quality, safety, and performance standards set by regulatory bodies like the FDA, EMA, and ISO.

These regulations require extensive validation, sterility testing, and quality control procedures, increasing production costs and time-to-market for new culture media products. These costs could be barrier to several market players who are innovating advanced microbiology systems or microbiology cultures with different compositions.

Segment Analysis

The global microbiology culture market is segmented based on the product type, culture type, consistency, application, and region.

Culture equipment in the product type segment is expected to dominate the microbiology culture market

Culture equipment plays a crucial role in the microbiology culture market by enabling precise microbial growth, monitoring, and analysis across various industries, including pharmaceuticals, clinical diagnostics, and food safety. Culture equipment comprises incubators, bioreactors, analytical devices, sterilization equipment, and others. Bioreactors are essential in microbiology culture, enabling the controlled growth of cells and microorganisms for drug production, vaccine development, and research. Sterilization equipment also plays a critical role in the microbiological culture market, as it ensures the prevention of contamination and maintains the integrity of cell cultures, which is essential for accurate research and experimentation.

Mergers and acquisitions (M&A) and collaborations play a crucial role in driving growth, innovation, and market expansion in the culture incubator and microbiology culture equipment sectors. For instance, in January 2023, Culture Biosciences and Cytiva teamed up to enhance upstream bioprocessing by integrating Culture's 250mL and 5L single-use bioreactors into Cytiva's Bioreactor Scaler tool. The 250mL bioreactors, mounted in mobile cart modules of four, support mammalian cell culture and microbial fermentation.

Geographical Analysis

North America is expected to dominate the microbiology culture market

North America, particularly the United States and Canada, holds a dominant position in the global microbiology culture market. The region's robust healthcare systems, including hospitals, clinics, and diagnostic laboratories, fuel the need for microbiology culture products.

Moreover, the rising prevalence of infectious diseases and the increasing focus on antimicrobial resistance further drive the market growth in the region. For instance, the Centers for Disease Control and Prevention (CDC) estimates that Salmonella causes approximately 1.35 million infections annually in the United States. This widespread bacterial infection is one of the country's most common causes of foodborne illness. It leads to about 26,500 hospitalizations and 420 deaths each year.

With this high incidence of Salmonella infections, there is a higher demand for microbiology cultures to detect pathogens in food, water, and clinical samples. Laboratories use microbiology culture media to grow and identify harmful microorganisms, leading to more sales of specialized culture products and testing kits.

The rising adoption of personalized medicine and microbial-based therapeutics is driving market expansion by enabling targeted treatments tailored to individual patient needs. Thus, the above factors are expected to drive the region's growth by solidifying the region's growth in the global microbiology culture market.

Competitive Landscape

The global market players in the microbiology culture market are Danaher (Cytiva), BD, Merck KGaA, Thermo Fisher Scientific Inc., Sartorius AG, Eiken Chemical co. Lti., HiMedia Laboratories Pvt. Ltd, Kerry Group Plc, BioMerieux S.A., Mettler Toledo, Yokogawa Electric Corporation, Conda Laboratories S.A, SATAKE MultiMix Corporation, B.E. MARUBISHI CO., LTD., and ABLE Corporation & Biott Corporation among others.

Key Developments

  • In November 2024, Dedalus Group and Ibex Medical Analytics have launched a fully integrated End-to-End AI-powered Digital Pathology Solution for cancer diagnosis, now commercially available in major European markets. The solution sets a new standard for anatomic pathology lab digitization by seamlessly integrating Ibex's GalenTM platform into Dedalus' comprehensive Digital Pathology (DP) Solution.
  • In September 2024, Roche has expanded its digital pathology open environment with over 20 AI algorithms from eight new collaborators, aiming to support pathologists and scientists in cancer research and diagnosis by leveraging advanced AI technology

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global microbiology culture market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Culture Type
  • 2.5. Snippet by Consistency
  • 2.6. Snippet by Application
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Infectious Diseases
      • 3.1.1.2. Increasing R&D Investments in Microbiology and Life Sciences
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent Regulatory Framework for Culture Media Production
      • 3.1.2.2. Risk of Contamination and Inconsistent Results
    • 3.1.3. Opportunity
      • 3.1.3.1. Potential for Innovative Culture Media for Fastidious Microorganisms
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Microbiology Culture Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Culture Equipment*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Bioreactors
      • 5.2.3.1. Bioreactor Devices
      • 5.2.3.2. Measuring Instruments
      • 5.2.3.2.1. PH Sensors
      • 5.2.3.2.2. Dissolved Oxygen Sensors
      • 5.2.3.2.3. Temperature Sensors
      • 5.2.3.2.4. Others
      • 5.2.3.3. Analytical Devices
      • 5.2.3.3.1. Cell Counters
      • 5.2.3.3.2. Spectrometers
      • 5.2.3.3.3. Others
      • 5.2.3.4. Sterilization Equipment
      • 5.2.3.5. Incubators
      • 5.2.3.6. Others
  • 5.3. Culture Supplements
  • 5.4. Measuring Instruments
    • 5.4.1. PH Sensors
    • 5.4.2. Temperature Sensors
    • 5.4.3. Dissolved Oxygen Sensors
    • 5.4.4. Others
  • 5.5. Culture Instruments
    • 5.5.1. Petri Dishes
    • 5.5.2. Loops & Needles
    • 5.5.3. Micropipettes
    • 5.5.4. Centrifuge
    • 5.5.5. Others
  • 5.6. Analytical Devices
    • 5.6.1. Cell Counters
    • 5.6.2. Spectrometers
    • 5.6.3. Others

6. Microbiology Culture Market, By Culture Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 6.1.2. Market Attractiveness Index, By Culture Type
  • 6.2. Eukaryotic Culture*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bacterial Culture

7. Microbiology Culture Market, By Consistency

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 7.1.2. Market Attractiveness Index, By Consistency
  • 7.2. Liquid Media*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Solid Culture Media
  • 7.4. Semi-solid Media

8. Microbiology Culture Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Food & Beverage Industry
  • 8.4. Others
  • 8.5. Water Testing
  • 8.6. Cosmetics

9. Microbiology Culture Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Danaher (Cytiva)*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. BD
  • 11.3. Merck KGaA
  • 11.4. Thermo Fisher Scientific Inc.
  • 11.5. Sartorius AG
  • 11.6. Eiken Chemical co. Lti.
  • 11.7. HiMedia Laboratories Pvt. Ltd
  • 11.8. Kerry Group Plc
  • 11.9. BioMerieux S.A.
  • 11.10. Mettler Toledo
  • 11.11. Yokogawa Electric Corporation
  • 11.12. Conda Laboratories S.A
  • 11.13. SATAKE MultiMix Corporation
  • 11.14. B.E. MARUBISHI CO., LTD.
  • 11.15. ABLE Corporation & Biott Corporation

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us